For press inquiries click here to contact us.
Medium
Foresite Labs: Supporting the Next Generation of Healthcare Entrepreneurs
Endpoint News
Vik Bajaj unveils Foresite’s new incubator, looking to hatch future giants crossing tech and healthcare
STAT
Pharma and biotech should embrace ‘Medicare for all,’ not defeat it
The PE Hub Network
Foresite recruits Smith as IR head
KNect365
Nine VCs who matter, but you never read about
The Full Ratchet
Growth Investing in Biotech, Genomics and Pharma (Jim Tananbaum)
The Bio Report
Why Foresite Capital is Betting Big on the Convergence of AI and Biotech
Business Insider
‘We’re a proudly geeky crew:’ A VC that manages $2 billion explains why he plans to stick with investments until they’re profitable
Wall Street Journal
Foresite Capital Closes $668 Million Fund, its Largest Yet
Recognitions by unaffiliated third parties should not be construed as a current or past endorsement of Foresite Capital Management, LLC (“Foresite Capital”) or the private funds it manages. The rankings and recognitions published by Forbes are based on information prepared and submitted by Foresite Capital. Third party ratings are not representative of an individual investor’s investment results or the results of Foresite Capital and its funds. Past performance is no guarantee of future results. Please contact Foresite Capital for more detail on the criteria upon which the Forbes Midas List is based.